Skip to main content
. 2020 Sep 11;3(9):e2016256. doi: 10.1001/jamanetworkopen.2020.16256

Table. Characteristics of HIV-Negative MSM Using and Sharing PrEP Medication in a Diverse Sample From 3 US Cities, 2018.

Characteristic Total No. (%) PrEP users PrEP users who share medication
No. (%) χ2 P valuea aOR (95% CI) aOR P value No. (%) χ2 P valuea aOR (95% CI) aOR P value
Overall 755 (100) 243 (32.2) NA NA 26 (10.7) NA NA
Race/ethnicity
Latino/Hispanic 95 (12.6) 28 (29.5) .13 1.33 (0.85-2.10) .21 5 (17.9) .29 0.27 (0.07-1.09) .07
Black/African American 146 (19.3) 38 (26.0) 0.80 (0.51-1.25) .33 2 (5.4) 0.34 (0.07-1.66) .18
Other/mixed 115 (15.2) 45 (33.1) 0.74 (0.45-1.23) .25 3 (6.7) 1.23 (0.37-4.11) .73
White 399 (52.9) 132 (39.1) 1 [Reference] NA 16 (12.1) 1 [Reference] NA
Age group, y
18-29 341 (45.2) 103 (30.2) .04 1.28 (0.84-1.93) .25 12 (11.8) .03 12.19 (1.43-103.86) .02
30-39 231 (30.6) 89 (38.5) 1.70 (1.11-2.61) .02 13 (14.6) 9.78 (1.19-80.23) .03
≥40 183 (24.2) 51 (27.9) 1 [Reference] NA 1 (2.0) 1 [Reference] NA
Educational level
≤Some post–high school 262 (34.8) 62 (23.7) <.001 1 [Reference] NA 4 (6.6) .01 1 [Reference] NA
4-Year college degree 280 (37.2) 96 (34.3) 1.54 (1.04-2.29) .03 4 (6.3) 0.73 (0.19-2.86) .65
>4-Year college degree 211 (28.0) 85 (40.3) 2.04 (1.34-3.10) .001 16 (18.8) 3.67 (1.06-12.73) .04
City/MSA
Atlanta, Georgia 269 (35.6) 88 (32.7) <.01 1 [Reference] NA 8 (9.1) .78 1 [Reference] NA
Detroit, Michigan 226 (39.9) 56 (24.8) 0.64 (0.43-0.97) .03 6 (10.7) 0.75 (0.23-2.52) .65
New York City, New York 260 (34.4) 99 (38.1) 1.15 (0.79-1.68) .46 12 (12.2) 1.39 (0.50-3.87) .53

Abbreviations: aOR, adjusted odds ratio; MSA, metropolitan statistical area; MSM, men who have sex with men; NA, not applicable; PrEP, pre-exposure prophylaxis.

a

P < .05 indicated statistical significance for the χ2 test.